© 2022 MJH Life Sciences and Ophthalmology Times. All rights reserved.
© 2022 MJH Life Sciences™ and Ophthalmology Times. All rights reserved.
December 15, 2021
SD-OCT is providing reproducible, high-quality, registered images to assess the treatment response in macular disease.
December 02, 2021
Successful treatment options can offer hope for patients with inherited disease.
November 29, 2021
Investigators believe the therapy could prove to be an option for the treatment of other retinopathies.
November 25, 2021
Investigators find that youth show altered ocular movements, reduced amplitude of accommodation.
November 24, 2021
The unique MOA may deliver a synergistic effect when prescribed post-surgically.
November 23, 2021
An experience at the grocery store serves as a reminder of the importance of fundraising for eye research.
November 03, 2021
Pilot study tests the technology to obtain remote fundus imaging of patients.
November 02, 2021
Staying current on phaco technology can help surgeons provide better outcomes.
November 01, 2021
The FDA has given its approval to Byooviz (ranibizumab-nuna, SB11, Samsung Bioepis Co Inc and Biogen Inc), a biosimilar referencing Lucentis (ranibizumab, Genentech).
Re-Vana Therapeutics raises $11.9 million in Series A financing for development of ophthalmic therapeutics
Harrow and iOR Partners expand national product supply agreement
OWL, WIO to co-host networking reception during Hawaiian Eye